Gene Therapy on Trial
- 12 May 2000
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 288 (5468) , 951-957
- https://doi.org/10.1126/science.288.5468.951
Abstract
A flurry of reports and congressional hearings, sparked by the death of a volunteer in a study at the University of Pennsylvania in Philadelphia last fall, are due in the next few weeks. The Penn episode points up a central problem: The field still lacks an ideal vector. Many clinicians fear that support for gene therapy will buckle under the onslaught.This publication has 0 references indexed in Scilit: